Resveratrol inhibits nonalcoholic fatty liver disease in rats

BACKGROUND: The prevalence of nonalcoholic fatty liver disease (NAFLD) is high. NAFLD is linked to obesity, diabetes mellitus, and hypertriglyceridemia. Approximately 20% of patients with NAFLD will eventually develop cirrhosis. Our purpose was to investigate whether resveratrol decreased hepatic st...

Descripción completa

Detalles Bibliográficos
Autores principales: Bujanda, Luis, Hijona, Elizabeth, Larzabal, Mikel, Beraza, Marta, Aldazabal, Pablo, García-Urkia, Nerea, Sarasqueta, Cristina, Cosme, Angel, Irastorza, Belen, González, Alberto, Arenas, Juan I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2547101/
https://www.ncbi.nlm.nih.gov/pubmed/18782455
http://dx.doi.org/10.1186/1471-230X-8-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2547101/
https://www.ncbi.nlm.nih.gov/pubmed/18782455
http://dx.doi.org/10.1186/1471-230X-8-40

Ejemplares similares